using organoid to simulate and study the pathogenesis of esophageal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034996

Enrollment

Unknown

Registered

2020-07-27

Start date

2018-10-16

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Case series:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all patients that confirmed as esophageal precancerous lesion or cancer are eligible.

Exclusion criteria

Exclusion criteria: 1. preganant women; 2. unsuitable for biopsy; 3. decline to participate.

Design outcomes

Primary

Measure	Time frame
gene mutation;	—

Countries

China

Contacts

Public ContactHu Bing

West China Hospital, Sichuan University

hubing@163.com+86 18980601278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026